510(k) Report

PMA · Approved

Recalled · Class II · 2023

Guardian System

P150009PMAApproved Apr 9, 20181,141-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Avertix Medical, Inc. · QBI Acute Coronary Syndrome Event Detector

Approved on Apr 9, 2018 through premarket approval, which rests on the device’s own clinical evidence after a 1,141-day review. It has been recalled once.

Decided
Apr 9, 2018
Review
1,141 days
Class
Class III
Product code
QBI
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P150009 has 12 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2018: 12020: 22021: 32022: 22023: 12024: 3
2018high 3 (2021) · low 0 (2019)2024
View FIG. 1 as a table
YearSupplements approved
20181
20202
20213
20222
20231
20243
FIG. 1 — Supplements to P150009, 2018–2024Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QBI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 1, 2023Class IIZ-1140-2025Process controlDevice reaching End of Service prematurely.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QBI devices

QBI Acute Coronary Syndrome Event Detector: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · QBI

3in 2024

2018: 22020: 22021: 32022: 22023: 12024: 3
2007high 3 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBI

Too few QBI 510(k)s in any year since 2007 to give a median.

Recalls per year · QBI

No recall names QBI since 2007.

Adverse event reports per year · QBI

35in 2025

2023: 92024: 122025: 35
2007high 35 (2025) · low 0 (2007)2025

MAUDE reports naming product code QBI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20182—00
20190—00
20202—00
20213—00
20222—00
20231—09
20243—012
20250—035
20260—0—
Cite this page

510(k) Report. “P150009: Guardian System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P150009

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026